Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Integrated Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010914
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integrated Diagnostics Inc (Indi) is a medical device company that develops and distributes blood based molecular diagnostics tests for the healthcare markets. The company provides product such as xpresys lung that helps physicians to diagnose complex diseases with a non-invasive blood test. Its other products include PET scan, bronchoscopy, needle biopsy, and others. Indi’s xpresys lung is a molecular blood test that offers non-invasive, objective information for the assessment of pulmonary nodules. It concentrates on research and development of diagnostics and measurement technologies used for measuring several bio-markers simultaneously for improved diagnosis and accurate management of complex diseases. Indi is headquartered in Seattle, Washington, the US.

Integrated Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Integrated Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Integrated Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Partnerships 17
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Integrated Diagnostics Inc – Key Competitors 19
Integrated Diagnostics Inc – Key Employees 20
Integrated Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Integrated Diagnostics Inc, Medical Equipment, Key Facts 2
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Integrated Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Integrated Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Integrated Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Integrated Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Integrated Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Integrated Diagnostics Raises USD6 Million in Series C Financing 10
Integrated Diagnostics Raises USD6.1 Million in Venture Financing 11
Integrated Diagnostics Raises US$30 Million In Series B Financing 12
Integrated Diagnostics Secures USD1.5 Million Funding from Interwest Partners 14
Integrated Diagnostics Raises US$10 Million In Third Tranche Of Series A Financing 15
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 17
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics 18
Integrated Diagnostics Inc, Key Competitors 19
Integrated Diagnostics Inc, Key Employees 20

★海外企業調査レポート[Integrated Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seven Seas Cruises S. DE R.L.:企業の戦略・SWOT・財務情報
    Seven Seas Cruises S. DE R.L. - Strategy, SWOT and Corporate Finance Report Summary Seven Seas Cruises S. DE R.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Rebiotix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that develops treatments for debilitating diseases. The company targets various disease conditions using drugs based on its microbiota restoration therapy platform. It lead product candidate RBX2660 is u …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Trinity Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Trinity Health (Trinity) formerly known as CHE Trinity Health, is a national Catholic health care organization that provides health care solutions in the US. It operates through a network of hospitals, health care services, and advocate partnerships at community, regional, and national level …
  • Alcami Corp:企業の戦略的SWOT分析
    Alcami Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Innergex Renewable Energy Inc (INE):電力:M&Aディール及び事業提携情報
    Summary Innergex Renewable Energy Inc (Innergex) is an independent renewable power producer. It develops, acquires, owns and operates hydroelectric facilities, wind farms, and solar photovoltaic geothermal power facilities. Through long-term power purchase agreements, the company sells electricity t …
  • Global Alliance for TB Drug Development:製薬・医療:M&Aディール及び事業提携情報
    Summary Global Alliance for TB Drug Development (TB Alliance) is a non-profit organization that discovers and develops drugs to treat tuberculosis. The organization’s products include natural products, rifampin, pyrazinamide, isoniazid, macrokuds, ethambutol, and topoisomerase inhibitors. It offers …
  • ArmaGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ArmaGen Inc (ArmaGen), formerly ArmaGen Technologies Inc is a clinical stage biotechnology company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include AGT-181, AGT-182, AGT-183, AGT-184, AGT-187, AGT-115, AGT-190, AGT-110 and AGT …
  • Toyota Motor Corp (7203):企業の財務・戦略的SWOT分析
    Toyota Motor Corp (7203) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Star Buffet, Inc (STRZ):企業の財務・戦略的SWOT分析
    Star Buffet, Inc (STRZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Casella Waste Systems Inc (CWST):企業の財務・戦略的SWOT分析
    Summary Casella Waste Systems Inc (Casella Waste) is a solid waste management company that offers resource and waste management services. The company's services include landfills, recycling, collection, organics, energy, and sustainability services, among others. Its recycling services comprise elec …
  • BioElectronics Corp (BIEL):企業の財務・戦略的SWOT分析
    BioElectronics Corp (BIEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SteadyMed Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Exonate Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs, which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The company’s alternative mRNA splicing is modulated in disease states that results in the pathologic …
  • Lam Research Corp (LRCX):企業の財務・戦略的SWOT分析
    Lam Research Corp (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Philip Morris International Inc (PM):企業の財務・戦略的SWOT分析
    Philip Morris International Inc (PM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bauer AG (B5A):企業の財務・戦略的SWOT分析
    Bauer AG (B5A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆